A detailed history of Dempze Nancy E transactions in Danaher Corp stock. As of the latest transaction made, Dempze Nancy E holds 17,196 shares of DHR stock, worth $4.13 Million. This represents 3.69% of its overall portfolio holdings.

Number of Shares
17,196
Previous 16,270 5.69%
Holding current value
$4.13 Million
Previous $3.76 Million 14.11%
% of portfolio
3.69%
Previous 3.57%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$224.58 - $256.19 $207,961 - $237,231
926 Added 5.69%
17,196 $4.29 Million
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $88,107 - $110,969
476 Added 3.01%
16,270 $3.76 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $28,202 - $32,136
121 Added 0.77%
15,794 $3.92 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $53,997 - $61,473
240 Added 1.56%
15,673 $3.76 Million
Q1 2023

May 10, 2023

BUY
$239.75 - $277.0 $42,915 - $49,583
179 Added 1.17%
15,433 $3.89 Million
Q4 2022

Feb 09, 2023

BUY
$241.42 - $282.29 $73,874 - $86,380
306 Added 2.05%
15,254 $4.05 Million
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $29,647 - $180,888
120 Added 0.81%
14,948 $3.86 Million
Q2 2022

Jul 19, 2022

SELL
$237.11 - $299.66 $561,476 - $709,594
-2,368 Reduced 13.77%
14,828 $3.76 Million
Q1 2022

May 17, 2022

SELL
$257.27 - $315.76 $19,809 - $24,313
-77 Reduced 0.45%
17,196 $5.04 Million
Q4 2021

Feb 08, 2022

SELL
$292.08 - $329.01 $2,336 - $2,632
-8 Reduced 0.05%
17,273 $5.68 Million
Q3 2021

Nov 10, 2021

SELL
$272.21 - $332.43 $568,374 - $694,113
-2,088 Reduced 10.78%
17,281 $5.26 Million
Q2 2021

Aug 09, 2021

SELL
$225.08 - $271.69 $226,430 - $273,320
-1,006 Reduced 4.94%
19,369 $5.2 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $98,544 - $114,097
-464 Reduced 2.23%
20,375 $4.59 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $144,925 - $167,403
-682 Reduced 3.17%
20,839 $4.63 Million
Q3 2020

Oct 28, 2020

SELL
$177.16 - $215.33 $205,328 - $249,567
-1,159 Reduced 5.11%
21,521 $4.63 Million
Q2 2020

Jul 28, 2020

SELL
$128.7 - $176.83 $83,268 - $114,409
-647 Reduced 2.77%
22,680 $4.01 Million
Q1 2020

May 07, 2020

SELL
$121.39 - $169.05 $90,435 - $125,942
-745 Reduced 3.09%
23,327 $3.23 Million
Q4 2019

Jan 15, 2020

SELL
$133.47 - $153.48 $9,209 - $10,590
-69 Reduced 0.29%
24,072 $3.69 Million
Q3 2019

Nov 07, 2019

SELL
$135.4 - $146.47 $275,539 - $298,066
-2,035 Reduced 7.77%
24,141 $3.49 Million
Q2 2019

Jul 24, 2019

SELL
$124.88 - $143.73 $232,401 - $267,481
-1,861 Reduced 6.64%
26,176 $3.74 Million
Q1 2019

May 01, 2019

SELL
$97.62 - $132.29 $7,614 - $10,318
-78 Reduced 0.28%
28,037 $3.7 Million
Q4 2018

Jan 24, 2019

SELL
$94.85 - $109.54 $97,505 - $112,607
-1,028 Reduced 3.53%
28,115 $2.9 Million
Q3 2018

Oct 15, 2018

BUY
$98.13 - $108.9 $10,892 - $12,087
111 Added 0.38%
29,143 $3.17 Million
Q2 2018

Jul 30, 2018

BUY
$96.1 - $103.24 $9,225 - $9,911
96 Added 0.33%
29,032 $2.87 Million
Q1 2018

Apr 24, 2018

BUY
$92.16 - $103.8 $58,521 - $65,913
635 Added 2.24%
28,936 $2.83 Million
Q4 2017

Feb 02, 2018

BUY
$85.26 - $94.62 $367,044 - $407,339
4,305 Added 17.94%
28,301 $2.63 Million
Q3 2017

Oct 26, 2017

BUY
$79.29 - $88.45 $1.9 Million - $2.12 Million
23,996
23,996 $2.06 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Dempze Nancy E Portfolio

Follow Dempze Nancy E and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

News

Stay updated on Dempze Nancy E with notifications on news.